Research Studies at Suburban Hospital

Research Trials: Oncology

For more information, please contact Suburban Hospital Oncology Research:
Barbara Squiller: 301-896-2719
Melissa Hyman: 301-896-3221

Topic Study Name Learn More Principal Investigator
Breast A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting (NALA) Learn More Carolyn Hendricks, M.D.
Breast A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer Learn More Carolyn Hendricks, M.D.
Breast Molecular Genetic Studies in Cancer Patients and Their Relatives   Carolyn Hendricks, M.D.
Breast A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculosketal Symptoms (AIMSS) Learn More Carolyn Hendricks, M.D.
Breast A Phase III Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or Less. Learn More Carolyn Hendricks, M.D.
Breast Phase II placebo-controlled trial of lisinopril and Coreg CR® to reduce cardiotoxicity in patients with breast cancer receiving (neo)adjuvant chemotherapy with trastuzumab (Herceptin®) Learn More Carolyn Hendricks, M.D.
Breast Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. Learn More  
Cancer STAR™ Tumor Ablation System Prospective Clinical Series, DF-13-FEB [The STAR Prospective Clinical Series]   Andrew Hines, M.D.
Liver Humanitarian Use of Intra-arterial Y-90 TheraSpheres for Hepatocellular Carcinoma or Hepatic Metastases from Solid Tumors   Andrew Hines, M.D.

Oncology Research Team